Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Comparison of Telbivudine Plus Adefovir With Lamivudine Plus Adefovir for the Treatment of Lamivudine-resistant Chronic Hepatitis B at 52 Weeks: A Pilot Study (TeSLA)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified March 2013 by Korea University.
Recruitment status was  Recruiting
Information provided by (Responsible Party):
Hyung Joon Yim, Korea University Identifier:
First received: December 23, 2011
Last updated: March 3, 2013
Last verified: March 2013
No Study Results Posted on for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: May 2014
  Estimated Primary Completion Date: December 2013 (Final data collection date for primary outcome measure)